CIK 0002023658 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bicara Therapeutics Inc.
Sign in to watch- Ticker
- BCAX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-468-4219
- Business address
- 116 HUNTINGTON AVENUE SUITE 703, BOSTON, MA, 02116
- 4 Planned sale President, COO & Interim CEO sold 17,500 shares at an average $22.90 ($400,716)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Financial Officer sold 12,500 shares at $27.97 ($349,591)
- 4 Planned sale Chief Executive Officer sold 10,000 shares at $27.98 ($279,750)
- 4 Planned sale President and COO sold 18,750 shares at $27.98 ($524,533)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Executive Officer sold 10,000 shares at an average $28.42 ($284,198)
- 4 Planned sale President and COO sold 28,750 shares at an average $28.98 ($833,129)
- 4 Planned sale Chief Financial Officer sold 28,000 shares at an average $28.85 ($807,672)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 1 of 6 · 107 filings